Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis.
Medicine (Baltimore)
; 102(36): e35004, 2023 Sep 08.
Article
in En
| MEDLINE
| ID: mdl-37682177
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Cyclin-Dependent Kinase Inhibitor Proteins
/
Kidney Neoplasms
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Medicine (Baltimore)
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: